Status:

ENROLLING_BY_INVITATION

Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH

Lead Sponsor:

Coordinación de Investigación en Salud, Mexico

Collaborating Sponsors:

University of Southampton

Universidad Nacional Autonoma de Mexico

Conditions:

Pulmonary Hypertension of Newborn

Diaphragm Defect

Eligibility:

All Genders

1-15 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate the effect of a parenteral emulsion containing n-3 long-chain polyunsaturated fatty acids (LC-PUFA) in fish oil on clinical outcomes, markers of inflammation a...

Detailed Description

Background. Persistent pulmonary hypertension of the newborn (PPHN), is a syndrome characterized by difficulty to provide normal pulmonary vasodilatation at birth or after birth, which may be related ...

Eligibility Criteria

Inclusion

  • Plan to administrate TPN for at least 7 days
  • Clinical, gasometric, and echocardiographic diagnosis of congenital diaphragmatic hernia.
  • Gestational age \>=34 weeks.
  • Written informed consent signed by both parents after an explanation of the objectives, procedures and possible risks and benefits of the research, along with the signature of two witnesses

Exclusion

  • Diagnosis of complex congenital cardiopathy
  • Cyanotic congenital cardiology defect
  • Insufficiency of the tricuspid valve
  • Immunosuppressive disease. HIV has been associated with PPHN and human herpesvirus with vascular remodeling, perivascular macrophages, and lung fibrosis
  • Clinical entities that preclude the total parenteral nutrition for one day or longer.
  • Presence of profuse and persistent haemorrhage at any level
  • Elimination criteria
  • Parents who withdraw their consent.
  • Starting a drug at doses for nonclotting treatment such as heparin, enoxaparin.
  • Development of profuse and persistent haemorrhage at any level after receiving vitamin K treatment.

Key Trial Info

Start Date :

August 12 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04031508

Start Date

August 12 2019

End Date

December 1 2026

Last Update

August 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unit of Medical Research in Nutrition

Mexico City, Mexico City, Mexico, 06720